期刊
NATURE REVIEWS MATERIALS
卷 6, 期 2, 页码 103-106出版社
NATURE PORTFOLIO
DOI: 10.1038/s41578-020-00277-6
关键词
-
资金
- Mayo Clinic Center for Regenerative Medicine in Florida
- National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), United States [R21AI152318, R01AI144997]
- NIH Common Fund through the Office of Strategic Coordination/Office of the NIH [UG3CA241694]
Cell-released biological nanoparticles, known as extracellular vesicles (EVs), are emerging drug carriers with high complexity. EV-based drug delivery leverages intrinsic mechanisms for molecular transport in the body, and integrating EV biology and manufacturing with clinical insights from synthetic nanoparticles is likely to significantly advance the field of drug delivery.
Cell-released biological nanoparticles, that is, extracellular vesicles (EVs), are emerging drug carriers with high complexity. EV-based drug delivery exploits intrinsic mechanisms for molecular transport in the body. Integrating EV biology and manufacturing with clinical insights from synthetic nanoparticles is likely to substantially advance the field of drug delivery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
